Phathom Pharmaceuticals Inc (PHAT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -221,247 | -334,326 | -201,592 | -197,723 | -143,883 |
| Depreciation Amortization | 3,647 | 2,987 | 2,452 | 2,730 | 4,116 |
| Accounts receivable | -39,331 | -37,160 | -1,637 | N/A | N/A |
| Other Working Capital | -12,376 | -15,298 | -13,644 | 5,438 | -27,315 |
| Other Operating Activity | 102,532 | 117,027 | 76,841 | 43,025 | 18,625 |
| Operating Cash Flow | $-166,775 | $-266,770 | $-137,580 | $-146,530 | $-148,457 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -229 | -135 | -1,634 | -1,041 | -328 |
| Investing Cash Flow | $-229 | $-135 | $-1,634 | $-1,041 | $-328 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 59,400 | 39,318 | N/A | 96,889 |
| Debt Repayment | N/A | N/A | N/A | N/A | -54,125 |
| Common Stock Issued | 1,638 | 123,374 | 155,587 | 24,596 | 1,944 |
| Common Stock Repurchased | -1,926 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 0 | 0 | 172,675 | 95,446 | 0 |
| Financing Cash Flow | $-288 | $182,774 | $367,580 | $120,042 | $44,708 |
| Beginning Cash Position | 300,125 | 384,256 | 155,890 | 183,419 | 287,496 |
| End Cash Position | 132,833 | 300,125 | 384,256 | 155,890 | 183,419 |
| Net Cash Flow | $-167,292 | $-84,131 | $228,366 | $-27,529 | $-104,077 |
| Free Cash Flow | |||||
| Operating Cash Flow | -166,775 | -266,770 | -137,580 | -146,530 | -148,457 |
| Capital Expenditure | -229 | -135 | -1,634 | -1,041 | -328 |
| Free Cash Flow | -167,004 | -266,905 | -139,214 | -147,571 | -148,785 |